Vanguard Large-Cap ETF (NYSEARCA:VV – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $262.85 and last traded at $262.72, with a volume of 93360 shares. The stock had previously closed at $262.22.
Vanguard Large-Cap ETF Stock Up 0.3 %
The company has a market cap of $37.81 billion, a P/E ratio of 25.46 and a beta of 1.01. The firm’s 50 day moving average is $252.65 and its two-hundred day moving average is $245.53.
Institutional Trading of Vanguard Large-Cap ETF
A number of institutional investors have recently bought and sold shares of the company. Evermay Wealth Management LLC bought a new position in shares of Vanguard Large-Cap ETF during the 2nd quarter worth about $31,000. Vermillion & White Wealth Management Group LLC bought a new position in shares of Vanguard Large-Cap ETF during the 4th quarter worth about $28,000. Red Tortoise LLC bought a new position in shares of Vanguard Large-Cap ETF during the 1st quarter worth about $34,000. Bangor Savings Bank bought a new position in shares of Vanguard Large-Cap ETF during the 1st quarter worth about $40,000. Finally, Pineridge Advisors LLC bought a new position in shares of Vanguard Large-Cap ETF during the 4th quarter worth about $41,000.
Vanguard Large-Cap ETF Company Profile
Vanguard Large-Cap Index Fund (the Fund) seeks to track the performance of a benchmark index that measures the investment return of large-capitalization stocks. The Fund employs a passive management investment approach designed to track the performance of the MSCI US Prime Market 750 Index, a diversified index predominantly made up of stocks of large United States companies.
See Also
- Five stocks we like better than Vanguard Large-Cap ETF
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Insider Trading – What You Need to Know
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Calculate Inflation Rate
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Vanguard Large-Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Large-Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.